Latest News
PMV Pharmaceuticals, Inc.
- PMV appoints Matt Eckler to board: 2027 filing plans matter for PMV Pharmaceuticals stock
- PMV appoints Matt Eckler: what the 2027 filing means for PMV Pharmaceuticals stock
- PMV Pharmaceuticals adds Matt Eckler and PMV Pharmaceuticals stock posts 21.60 percent YTD
- PMV Pharmaceuticals: Restoring Mutant P53 Could Create A Mispriced Cancer Opportunity
- PMV Pharmaceuticals rated Buy on promising ovar...
- PMV Pharmaceuticals Appoints Matt Eckler to Board Ahead of 2027 NDA Filing
- PMV Pharmaceuticals Appoints Matthew Joseph Eckler as Director; Files Initial Ownership Statement with SEC
Headlines from the last 30 days, linking to the original publishers. See all market news →